Online citations, reference lists, and bibliographies.

Use Of Statins And Risk Of Fractures

Tjeerd-Pieter van Staa, Sebastiaan Wegman, Frank de Vries, Bert Leufkens, Cyrus Cooper
Published 2001 · Medicine
Cite This
Download PDF
Analyze on Scholarcy

This paper is referenced by
Could statin reduce fracture risk ? Evidence from a systematic review and meta-analysis
Yulei Gao (2016)
Association of Statins and Risk of Fractures in a Military Health System
I. Ward (2014)
Osteoporosis y enfermedad cardiovascular
Sarahí Mendoza (2007)
Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling
Misuzu Yamashita (2010)
Effect of simvastatin treatment on bone mineral density in hypercholesterolemic postmenopausal women
D. Janković (2005)
Pleiotropic effects of HMG-CoA reductase inhibitors
Nikos Werner (2002)
Chronic statin therapy and the risk of colorectal cancer.
Yu-Xiao Yang (2008)
Statin but not Non-Statin Lipid-Lowering Drugs Decrease Fracture Risk: A Nation-Wide Case-Control Study
Lars Rejnmark (2006)
Le biais de temps immortel dans les études pharmacoépidémiologiques : définition, solutions et exemples
Jean-Luc Faillie (2015)
Implications of immortal person-time when outcomes are nonfatal.
Caihua Liang (2016)
Effet des médicaments de l’ostéoporose sur les maladies cardiovasculaires et effet des médicaments à visée cardiovasculaire sur l’ostéoporose
Michel Laroche (2017)
Effects of simvastatin on the development of osteopenia caused by ovariectomy in rats.
Maria Pytlik (2003)
Association between serum cholesterol and bone mineral density.
Joanna Makovey (2009)
L'ostéoporose : épidémiologie, clinique et approches thérapeutiques
Aurélie Fontana (2001)
The role of statins in clinical medicine--LDL--cholesterol lowering and beyond.
J. Rutishauser (2006)
Potential Use of HMG-CoA Reductase Inhibitors for Osteoporosis
Lolita M Cushenberry (2002)
The effect of HMG-CoA reductase inhibitor (lovastatin) on bone mineral density (BMD) in postmenopausal women with type 2 diabetes
H. Safaei (2005)
[Cardiovascular disease and bone metabolism].
Rebeca Reyes-García (2011)
Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
Hongyu Qiu (2013)
Hip fracture risk in statin users—a population-based Danish case-control study
Lars Rejnmark (2003)
The potential effects on fracture outcomes of improvements in persistence and compliance with bisphosphonates.
Stephan Rietbrock (2009)
Immortal time bias in observational studies of drug effects.
S. Suissa (2007)
The effects of one-year simvastatin therapy on women’s bone mineral density
A. Dimić (2010)
The influence of simvastatin in rats mandible and femur bone mass under Freund's adjuvant arthritis.
Nikos Seferos (2012)
Statins and menopausal health
Alfred Otto Mueck (2002)
Fluvastatin does not elevate periosteal osteogenesis induce by Moloney sarcoma virus (MSV) in mice.
Ryszard Galus (2006)
Simvastatin did not prevent nor restore ovariectomy-induced bone loss in adult rats.
Wei Yao (2006)
The effects of one-year simvastatin therapy on women’s bone mineral density
A. Dimić (2010)
Statin use and risk of fracture: a meta-analysis.
Shaolin Jin (2015)
Does design matter? Systematic evaluation of the impact of analytical choices on effect estimates in observational studies
David Madigan (2013)
Können Statine den Knochenstoffwechsel positiv beeinflussen
Lorenz Vock (2005)
Statins and Menopause
Mohammed H. Moghadasian (2002)
See more
Semantic Scholar Logo Some data provided by SemanticScholar